Held at the Tampa Marriott Waterside Hotel & Marina, symposia are free of charge and most are approved for CRCE credit. The schedule below shows the companies hosting the symposia. Please note that the companies provided all topics, speakers, and descriptions, and they (not the AARC) are fully responsible for information presented at these sessions.
Complimentary breakfast and/or lunch. Attendance is limited, first-come, first-served once registration opens.
6:30 am–8:10 am, Saturday, Nov. 7 (Grand Ballroom, Salons A–D)
The Link Between Sedation and Asynchrony
Richard Branson MS, RRT, FAARC, FCCM, Cincinnati, OH
Presented by Medtronic
Program Overview
While ventilation may be a life-saving tool for critically ill patients, it can also be an uncomfortable experience due to the invasiveness of the tubing, and mismatches (or “asynchronies”) between the patient’s demand for breath and the ventilator-delivered breathing pattern.
In the past, clinicians addressed ventilator-patient asynchrony through heavy sedation. However, recent studies have highlighted the negative consequences of oversedation for ventilatory patients, which include muscle atrophy from prolonged disuse and lengthened ventilation times.
By evaluating for asynchrony, clinicians may be able to reduce the risk of oversedation. By using sedation more effectively, we can work together to potentially reduce ICU ventilation time.
Learning Objectives
Gain awareness of asynchrony and the effect of sedation on muscle atrophy
Understand how conventional ventilation modes work — benefits and limitations of each considering the patient’s natural breathing pattern
Learn how to identify asynchrony and assess the causes
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 145415000.
6:30 am–8:15 am, Saturday, Nov. 7 (Grand Ballroom, Salons G–J)
Noninvasive Monitoring of Gas Exchange: Preemies to Senior Citizens
Brandon Kuehne MBA, RRT-NPS, RPRT, Columbus, OH
Michael A. Gentile RRT, RCP, FAARC, Durham, NC
Presented by Sentec
Current Trends in the NICU — Opportunities and Challenges related to Non-Invasive Monitoring
Brandon Kuehne MBA, RRT-NPS, RPFT, Columbus, OH
Program Overview
This presentation discusses the current attitudes towards ventilation and the assessment of oxygenation in the NICU Environment.
Learning Objectives
Understand current goals and ventilatory strategies in the NICU
Understand current methods of assessing ventilation and oxygenation via evidence based practice
Discuss opportunities for translational research related to both tcPCO2 and tcPO2 in the Perinatal environment
Transcutaneous Monitoring of Gas Exchange: “It’s Not Just Kids’ Stuff”
Michael A. Gentile RRT, RCP, FAARC, Durham, NC
Program Overview
Due to advances in technology, the use of gas exchange monitoring has expanded. This presentation will discuss the clinical application of this technology in multiple patient populations.
Learning Objectives
Describe the technology used in transcutaneous monitors.
Discuss the patients and pathologies who may be monitored by transcutaneous devices.
Review the literature supporting the use of transcutaneous monitoring of gas exchange.
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 145284000.
7:00 am–8:00 am, Sunday, Nov. 8 (Grand Ballroom, Salons A–D)
Supporting Safety: Continuous Monitoring of Non-Critical Care Patients
George L. Barkema, RRT, Fairfax, VA
Presented by Masimo
Program Overview
This presentation will review continuous monitoring of non-critical care patients and the effects this monitoring modality can have on patient safety. Attendees will learn how respiratory therapists can drive change with regards to patient monitoring and patient safety. Also covered will be the potential benefits this monitoring modality can have across a care area, across a hospital, and across a health system.
Learning Objectives
Understanding the RT role in regards to patient monitoring and safety
Discuss why and how RT’s can and should drive change
Reasons for adopting continuous monitoring of non-critical care patients
How the continuous monitoring modality can help institutions achieve their goals
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory. Course number: 1452360000.
7:00 am–8:15 am, Sunday, Nov. 8 (Grand Ballroom, Salons G–J)
A Nebulized Long-Acting Beta2-Agonist for the Maintenance Treatment of COPD: Who, When, and Why?
Manuel Suarez-Barcelo, MD, CMD, Miami, FL
Presented by Mylan Pharmaceuticals
Program Overview
This session will be an interactive discussion and presentation of COPD, the importance of reevaluating your patients’ profiles, and clinical review of an FDA-approved nebulized product used in the maintenance treatment of COPD.
Please pre-register for the Mylan Product Workshop by emailing staff@maturehealth.com. Please provide your First and Last name, Affiliation, Specialty (RN, RPH, PhD), Address, License number/NPI Number, and License/NPI Number Expiration Date.
This course is not eligible for continuing education, nor does the American Association for Respiratory Care approve it for Continuing Respiratory Care Education (CRCE) credit.
12:35 pm–1:35 pm, Sunday, Nov. 8 (Grand Ballroom, Salons A–D)
Impact of IPV Device Safety on Institutional Risk and Quality. What Does It Mean for the RT?
Richard Branson MS, RRT, FAARC, Cincinnati, OH
Garry Kauffman RRT, FAARC, MPA, FACHE, Winston-Salem, NC
Presented by Mallinckrodt
Program Overview
Review the administration of inhaled pulmonary vasodilators (IPVs) to patients with acute pulmonary hypertension, including concerns associated with IPV delivery, methods for assessing IPVs, and institutional considerations for IPV use.
Learning Objectives
Outline some key risks associated with the delivery of inhaled pulmonary vasodilators (IPV) to patients with acute pulmonary hypertension
Examine features of 3 commonly used IPV delivery device
Discuss methods for assessing IPVs and the respiratory therapist’s professional responsibilities when administering IPVs
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 145018000.
6:00 am–8:00 am, Monday, Nov. 9 (Grand Ballroom, Salons A–D)
Using Physiology to Personalize Mechanical Ventilation
Leo Heunks MD, PhD, Nijmegen, The Netherlands
Presented by Maquet
Program Overview
Join us at the 2015 Maquet Breakfast Symposium for a discussion of the latest clinical research regarding neurally adjusted ventilatory assist (NAVA®) and Edi monitoring for adults. The session will provide an overview of how this technology is being used around the world and how it may be applied to your day-to-day practices to support personalized patient care.
Learning Objectives
Gain a better understanding of respiratory muscle monitoring and decision support, mechanical ventilation during sleep and sedation, and ventilator-induced lung injury (VILI) with a focus on clinician versus patient control.
Learn more about the latest in clinical research on the topics of neurally adjusted ventilatory assist (NAVA) and Edi monitoring.
Understand how NAVA and Edi monitoring have been used in daily care practice to better understand disease patterns and identify treatment strategies.
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 145304000.
6:00 am–8:00 am, Monday, Nov. 9 (Grand Ballroom, Salons G–J)
Respiratory Compromise: Common, Costly, Deadly and Preventable
Dean Hess PhD, RRT, Boston, MA
Neil MacIntyre MD, Durham, NC
Presented by Medtronic
Program Overview
Respiratory insufficiency, failure, and arrest are leading causes of mortality and ICU admissions, and create a significant cost burden to the healthcare system. Respiratory Compromise is listed among AHRQ’s top five conditions of increasing hospital cost which is projected to reach $37 billion by 2019. This symposium will discuss common pathways to respiratory compromise and explore potential strategies for prevention resulting in improved outcomes and reduced costs.
Learning Objectives
Define the respiratory compromise cascade and common pathways.
Identify common risk factors for development of respiratory compromise.
Explore potential early detection and prevention strategies.
This course has been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 145294000.
12:35 pm–1:35 pm, Monday, Nov. 9 (Grand Ballroom, Salons A–D)
The Role of Respiratory Care in Treating Idiopathic Pulmonary Fibrosis
Dennis K. Zawadski MD, Indianapolis, IN
Presented by Boehringer Ingelheim
Program Overview
Join us for a discussion about the diagnosis and treatment of IPF, focusing on the role of the healthcare professionals involved in patient care. The program will review key recommendations for IPF care and provide an overview of the use of OFEV® (nintedanib), an approved FDA-approved therapy for IPF.
Learning Objectives
Raise awareness about IPF through a review of diagnosis and symptoms.
Highlight key recommendations for symptom management.
Review OFEV® clinical data and the use of OFEV® for treating patients with IPF.
Admission to this course is complimentary. No registration is required. Seating is on a first come, first served basis. Seating is limited.
This course is not eligible for continuing education, nor does the American Association for Respiratory Care approve it for Continuing Respiratory Care Education (CRCE) credit.